PharmaLundensis AB Logo

PharmaLundensis AB

Develops treatments for heavy metal toxicity and serious respiratory illnesses.

PHAL | SPGR

Overview

Corporate Details

ISIN(s):
SE0003359710 (+5 more)
LEI:
54930082I88D5N3GQ506
Country:
Sweden
Address:
Scheelevägen 22, 223 63 Lund
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

PharmaLundensis AB is a pharmaceutical research company that develops treatments for diseases with significant unmet needs. The company's primary project is PHAL-501, a drug designed to bind and excrete heavy metals like mercury, lead, and cadmium from the body. PHAL-501 is intended to act within the intestine, capturing toxins before they are absorbed into the bloodstream, thus offering a potentially safe and effective treatment for heavy metal toxicity. In addition to this focus, the company is also involved in developing therapies for serious respiratory illnesses, such as chronic obstructive pulmonary disease (COPD).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PharmaLundensis AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmaLundensis AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmaLundensis AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-11 Tord Staffan Håkan Skogvall Other Buy 2,337 1,986.45 SEK
2025-01-17 SkåneÖrnen AB Other Buy 121,700 96,143.00 SEK
2025-01-17 Tord Staffan Håkan Skogvall Other Buy 10,958 7,999.34 SEK
2024-10-14 SkåneÖrnen AB Other Buy 49,370 19,748.00 SEK
2024-10-09 Tord Staffan Håkan Skogvall Other Buy 27,936 10,336.32 SEK
2024-09-26 SkåneÖrnen AB Other Buy 63,000 29,610.00 SEK
2024-09-20 Bo Wennergren Other Buy 60,000 27,600.00 SEK

Peer Companies

Company Country Ticker View
Cross Marketing Group Inc. Logo
Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.
Japan 3675
CrowdWorks Inc. Logo
Japan's largest crowdsourcing service with HR solutions and SaaS to connect companies and talent.
Japan 3900
C&R Research Inc. Logo
Leading South Korean CRO offering end-to-end clinical trial services for life science companies.
South Korea 359090
Curasight A/S Logo
Developing uPAR theranostics to precisely diagnose and treat cancers like brain and prostate.
Denmark CURAS
Cyclezyme AB Logo
Develops enzymatic solutions for recycling plastic waste into new raw materials.
Sweden CYCLE
Exploring for uranium & REEs, critical minerals for the clean energy and tech sectors.
Canada N/A
DBV Technologies Logo
Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.
France DBV
DD GROUP Co.,Ltd. Logo
Operates a diverse portfolio of food service, amusement, and hotel brands.
Japan 3073
A nationwide network of studios offering modern wedding photography and wellness services.
Japan 7372
Dedem SpA Logo
Diversified group providing photo booths, amusement rides, 3D printing, and tech solutions.
Italy DDM

Talk to a Data Expert

Have a question? We'll get back to you promptly.